CD82 Antikörper
-
- Target Alle CD82 Antikörper anzeigen
- CD82
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CD82 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
- Verwendungszweck
- CD82 Rabbit mAb
- Kreuzreaktivität
- Human, Maus
- Produktmerkmale
- Monoclonal Antibodies
- Aufreinigung
- Affinity purification
- Immunogen
- A synthesized peptide derived from human CD82
- Isotyp
- IgG
- Top Product
- Discover our top product CD82 Primärantikörper
-
-
- Applikationshinweise
- WB,1:500 - 1:2000,IHC,1:50 - 1:200,IF,1:50 - 1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide,0.05 % BSA,50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- CD82
- Andere Bezeichnung
- CD82 (CD82 Produkte)
- Hintergrund
- This metastasis suppressor gene product is a membrane glycoprotein that is a member of the transmembrane 4 superfamily. Expression of this gene has been shown to be downregulated in tumor progression of human cancers and can be activated by p53 through a consensus binding sequence in the promoter. Its expression and that of p53 are strongly correlated, and the loss of expression of these two proteins is associated with poor survival for prostate cancer patients. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008],4F9, C33, GR15, IA4, KAI1, R2, SAR2, ST6, TSPAN27,Cancer,CDs,Epigenetics & Nuclear Signaling,Immunology & Inflammation,Tumor suppressors,CD82
- Molekulargewicht
- 30-60kDa
- Gen-ID
- 3732
- UniProt
- P27701
- Pathways
- p53 Signalweg
-